Medication info
Hypezil 10mg (Donepezil Hydrochloride Hydrate)

Hypezil 10mg (Donepezil Hydrochloride Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Donepezil Hydrochloride Hydrate›10mg / 1 tablet
Manufacturer / importer
Hyundai Pharmaceutical Co., Ltd.
Appearance
Yellow round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200605443 · Notified 2006.06.22 · Insurance code 642002750

Summary

Main use
Treatment of symptoms of Alzheimer-type dementia
Who takes it
Adults · Children
Adult dose
○ Adults: Administer 5 mg of donepezil hydrochloride once daily at bedtime. If sleep disturbances such as abnormal dreams, nightmares, or insomnia occur, morning administration of this drug may be considered. Because donepezil concentrations reach steady state 15 days after administration and the incidence of adverse reactions may be affected by the rate of dose increase, administer the 5 mg dose for 4~6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg daily, administer with caution for gastrointestinal adverse reactions. When administration of this drug is discontinued, its effect gradually decreases; no rebound effect occurs upon abrupt discontinuation. ○ Women aged 85 years and older with low body weight: As adverse reactions occur more frequently, careful monitoring is required. Older women with low body weight should not exceed 5 mg daily.
Child dose
○ Children: There is no experience with use in children.

Ingredients

Manufacturer
Hyundai Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of symptoms of Alzheimer-type dementia

  • Symptoms of Alzheimer's dementia
View approved original text

This medicine is used for the treatment of symptoms of Alzheimer's dementia. Alzheimer's dementia is a condition characterized by memory loss and cognitive decline, and this medicine helps alleviate such symptoms and improve the patient's ability to carry out daily activities. It is effective in slowing the progression of dementia in patients and enhancing their quality of life.

How to take

Adult dose

○ Adults: Administer 5 mg of donepezil hydrochloride once daily at bedtime. If sleep disturbances such as abnormal dreams, nightmares, or insomnia occur, morning administration of this drug may be considered. Because donepezil concentrations reach steady state 15 days after administration and the incidence of adverse reactions may be affected by the rate of dose increase, administer the 5 mg dose for 4~6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg daily, administer with caution for gastrointestinal adverse reactions. When administration of this drug is discontinued, its effect gradually decreases; no rebound effect occurs upon abrupt discontinuation. ○ Women aged 85 years and older with low body weight: As adverse reactions occur more frequently, careful monitoring is required. Older women with low body weight should not exceed 5 mg daily.

Child dose

○ Children: There is no experience with use in children.

Precautions

This medicine contains Donepezil Hydrochloride Hydrate as the main ingredient and is used for the treatment of Alzheimer's dementia symptoms. First of all, this medicine should not be used in patients who are allergic to any of its ingredients or to Donepezil Hydrochloride or piperidine derivatives. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medicine. Patients with heart diseases, such as bradycardia or cardiac conduction disorders, should use this medicine with caution as it may slow heart rate or cause arrhythmias. Additionally, caution should be exercised when administering this medication to patients with a history of peptic ulcers or those taking non-steroidal anti-inflammatory drugs due to the risk of gastrointestinal bleeding or exacerbation of ulcers. Patients with asthma or obstructive pulmonary disease should also take care as this medicine may exacerbate symptoms by increasing bronchoconstriction and mucus secretion. Patients with extrapyramidal disorders, such as Parkinson's disease, may also need to be cautious as this medication could worsen symptoms. This medicine contains a dye called Yellow No. 5, and patients who are allergic to this substance should take it with caution. While taking this medicine, there may be heart-related adverse reactions such as syncope, bradycardia, heart block, myocardial infarction, and if symptoms occur, the patient should consult a physician immediately. Furthermore, serious side effects such as gastrointestinal bleeding, liver dysfunction, cerebrovascular accidents, extrapyramidal disorder symptoms, muscle disorders, respiratory distress, acute pancreatitis, and acute renal failure may rarely occur, so caution is necessary. Common side effects include nausea, vomiting, diarrhea, anorexia, dizziness, insomnia, headaches, fatigue, skin rashes, and if unusual symptoms persist, patients should inform the healthcare staff. This medicine is approved solely for patients with Alzheimer's dementia and should not be used for other forms of dementia or memory disorders. Treatment should be conducted under the supervision of an experienced physician, and regular assessments of treatment efficacy should be made to consider discontinuation if necessary. Patients with heart diseases or a history of QT interval prolongation may require an electrocardiogram due to the risk of arrhythmias. This medication can affect driving or operating machinery, so caution should be exercised during the initial stage of treatment or when the dose is changed. This medicine can interact with several drugs, so special care should be taken when taken with drugs that affect CYP3A4 or CYP2D6 metabolism, neuromuscular blockers, cholinergic drugs, anticholinergic drugs, and drugs that affect cardiac conduction, including NSAIDs. Pregnant or nursing mothers are advised not to take this medicine, and if absolutely necessary, breastfeeding should be discontinued. Safety in children has not been established, so it is not to be used in pediatric patients. In cases of overdose, serious symptoms such as nausea, vomiting, bradycardia, hypotension, respiratory depression, and seizures may occur, and immediate medical attention is required; antidotes such as atropine may be used. This medication should be kept out of reach of children and not transferred to other containers for safety.

Side effects

  • Syncope
  • bradycardia
  • cardiac block
  • QT interval prolongation
  • myocardial infarction
  • heart failure
  • peptic ulcer
  • perforated duodenal ulcer
  • gastrointestinal bleeding
  • hepatitis
Show 237 more
  • liver dysfunction
  • jaundice
  • cerebellar seizure
  • epilepsy
  • convulsions
  • cerebral hemorrhage
  • cerebrovascular disorders
  • motor dysfunction
  • ataxia
  • movement disorders
  • dystonia
  • tremors
  • involuntary movements
  • gait disturbances
  • abnormal posture
  • speech disorders
  • akinetic mutism
  • severe muscle rigidity
  • dysphagia
  • tachycardia
  • blood pressure fluctuations
  • sweating
  • myoglobinuria
  • renal dysfunction
  • myalgia
  • weakness
  • increased CK in blood and urine
  • rhabdomyolysis
  • dyspnea
  • acute pancreatitis
  • acute renal failure
  • sudden death
  • cold
  • anorexia
  • hallucinations
  • agitation
  • aggressive behavior
  • anxiety disorders
  • insomnia
  • drowsiness
  • increased libido
  • talkativeness
  • mania
  • nightmares
  • irritability
  • nonsensical talk
  • delusions
  • depression
  • confusion
  • apathy
  • hyperactivity
  • increased libido
  • hypersexuality
  • dizziness
  • tremors
  • seizures
  • stupor
  • thoracic rigidity
  • bradycardia
  • palpitations
  • sinoatrial block
  • atrioventricular block
  • hypertension
  • hypotension
  • atrial fibrillation
  • torsades de pointes
  • prolonged QT interval on ECG
  • diarrhea
  • nausea
  • vomiting
  • abdominal disturbances
  • gastrointestinal bleeding
  • gastric and duodenal ulcers
  • constipation
  • salivation
  • dysphagia
  • fecal incontinence
  • rash
  • pruritus
  • muscle cramps
  • myalgia
  • urinary incontinence
  • polyuria
  • urinary retention
  • headache
  • fatigue
  • pain
  • toothache
  • facial flushing
  • lethargy
  • asthenia
  • edema
  • fever
  • decreased body temperature
  • reduced hematocrit
  • leukopenia
  • anemia
  • thrombocytopenia
  • petechiae
  • abnormal dreams
  • accidents
  • back pain
  • chest pain
  • bleeding
  • eczema
  • urinary incontinence
  • elevated CPK
  • dehydration
  • hyperlipidemia
  • hypotension
  • abnormal ECG
  • heart failure
  • angina
  • congestive heart failure
  • peripheral vascular disease
  • supraventricular premature contractions
  • ventricular premature contractions
  • cardiac hypertrophy
  • constipation
  • gastroenteritis
  • fecal incontinence
  • dyspepsia
  • elevated γ-GT
  • gastritis
  • dysphagia
  • periodontitis
  • gastric ulcer
  • periodontal abscess
  • abdominal distension
  • liver dysfunction
  • belching
  • esophagitis
  • anal bleeding
  • diabetes
  • anemia
  • leukocytosis
  • weight loss
  • peripheral edema
  • edema
  • elevated LDH
  • increased alkaline phosphatase
  • hypercholesterolemia
  • hypokalemia
  • hypoglycemia
  • weight gain
  • hyperbilirubinemia
  • increased BUN
  • B12 deficiency anemia
  • cachexia
  • increased creatinine
  • gout
  • hyponatremia
  • hypoproteinemia
  • iron deficiency anemia
  • elevated AST
  • elevated ALT
  • arthritis
  • arthropathy
  • bone fracture
  • arthralgia
  • leg cramps
  • osteoporosis
  • myalgia
  • agitation
  • anxiety
  • tremors
  • convulsions
  • psychotic disorders
  • gait abnormalities
  • apathy
  • dizziness
  • delusions
  • abnormal dreams
  • cerebrovascular abnormalities
  • increased salivation
  • ataxia
  • ecstatic experiences
  • vasodilation
  • cerebral hemorrhage
  • cerebral infarction
  • cerebral ischemia
  • dementia
  • extrapyramidal symptoms
  • generalized tonic-clonic seizures
  • hemiplegia
  • hypertonia
  • decreased motor activity
  • pharyngitis
  • pneumonia
  • increased cough
  • bronchitis
  • dyspnea
  • rhinitis
  • asthma
  • rash
  • skin ulcers
  • itching
  • psoriasis
  • skin discoloration
  • shingles
  • dry skin
  • sweating
  • urticaria
  • vesicular rash
  • conjunctivitis
  • glaucoma
  • visual disturbances
  • ear pain
  • tear abnormalities
  • urinary tract infections
  • cystitis
  • hematuria
  • diabetes
  • vaginitis
  • dysuria
  • polyuria
  • proteinuria
  • abdominal pain
  • agitation
  • cholecystitis
  • confusion
  • convulsions
  • hallucinations
  • cardiac block
  • hemolytic anemia
  • hyponatremia
  • neuroleptic malignant syndrome
  • pancreatitis
  • rash
  • severe nausea
  • excessive salivation
  • hypotension
  • respiratory depression
  • weakness
  • convulsions
  • muscle weakness symptoms
  • respiratory muscle relaxation

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a tightly closed container that does not allow air to enter and should be kept at room temperature, between 1 to 30 degrees Celsius. Proper storage will maintain the medication's effectiveness and prevent deterioration.

Appearance and packaging

Appearance

Yellow round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.